News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Thermo Fisher Scientific (TMO) Release: New Next Generation Sequencing Solution Unlocks Door To Previously Inaccessible Gene Expression Data



9/3/2014 11:04:36 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CARLSBAD, Calif.--(BUSINESS WIRE)--Translational researchers who previously could not obtain global gene expression profiles from biobank samples due to limited amounts of tissue now have access to a wealth of valuable RNA data with the launch of the Ion AmpliSeq Transcriptome Solution for the Ion Proton System. The ability to mine many years worth of samples for critical information is expected to provide new insights into cancer research for diagnosis, prognosis and therapeutic options.

Its ability to draw gene expression profiles from just 10ng of RNA sets the Ion AmpliSeq Transcriptome Solution apart from other solutions in the market, and it is compatible with formalin-fixed, paraffin-embedded (FFPE) samples. This is critical to the needs of oncology and translational researchers. The Ion Ampliseq Solution also provides a faster and more cost-effective workflow without the sample manipulation required for microarrays or analytical complexity normally associated with whole transcriptome RNA-sequencing.

Hey, check out all the research scientist jobs. Post your resume today!

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES